pityriasis rubra pilaris/lafyèv

Lyen an sove nan clipboard la

AtikEsè klinikPatant

Chwazi kalite sòt

11 rezilta yo

[Acute pityriasis rubra pilaris in the child. Apropos of 4 cases].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Four cases of Pityriasis Rubra Pilaris of an acute type have been studied in three to six year old children. In three cases the disease occurred after an infection; in one out of these three cases this infection was serologically confirmed as being german measles. In the beginning, only the face is

Severe, Disfiguring, Pityriasis Rubra Pilaris in a Woman in the Dominican Republic: Histopathologic Diagnosis and Response to Antiretroviral Therapy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Pityriasis rubra pilaris (PRP) is a poorly understood dermatologic condition usually accompanied by keratoderma and intense erythroderma with islands of unaffected skin. The PRP categories include HIV-associated PRP VI. A 23-year-old HIV-infected, dark-skinned woman in the Dominican Republic

Pityriasis rubra pilaris with preceding cytomegalovirus infection.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Pityriasis rubra pilaris (PRP) is a papulosquamous disorder comprising 6 clinical types. Some factors - including abnormal vitamin A metabolism, internal malignancies, autoimmune diseases, infection and trauma - are thought to be involved in the etiology. Recently, human immunodeficiency virus

Pityriasis rubra pilaris exacerbation with topical use of imiquimod.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The role of immune response modifiers is increasing in the treatment of dermatologic diseases. Imiquimod, a toll-like receptor agonist, results in up-regulation of proinflammatory cytokines for improved immune surveillance. Although topical use is generally well-tolerated, imiquimod can potentially

Pityriasis rubra pilaris in a HIV-positive patient (Type 6 PRP).

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A 45-year-old previously healthy man presented with minimally itchy spiny papular lesions of 3 years' duration and discharging nodular cystic lesions for the past 2 years. Initially, lesions appeared on his ears, followed by the gradual appearance of similar lesions over his face, back, and

[Paraneoplastic pityriasis rubra pilaris in metastatic adenocarcinoma without diagnosable primary].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

METHODS A 75-year-old woman, without a history of severe illness, developed an erythematosquamous skin disease on hands and forearms. After continued spreading of these cutaneous lesions, she was admitted to hospital, presenting with a generalised desquamating erythrodermia and marked

[A case of pityriasis rubra pilaris associated with unclassified connective tissue disease and sepsis in clinical course].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The patient was a 23-year-old woman with HTLV-I carrier and was diagnosed as pityriasis rubra pilaris soon after her birth. In November 1990 at her age of 16, she began to have fever and polyarthralgia which were not improved despite the administration of antibiotics. Her laboratory findings showed

[Acute postinfectious pityriasis rubra pilaris: a superantigen-mediated dermatosis].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Acute postinfectious pityriasis rubra pilaris (PRP) is a variant of juvenile PRP (Griffiths type III) characterized by no family history, an acute course associated with a prior fever, and good prognosis. Clinical features may resemble other superantigen-mediated diseases, such as scarlatiniform

Erythroderma: a clinical study of 97 cases.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Erythroderma is a rare skin disorder that may be caused by a variety of underlying dermatoses, infections, systemic diseases and drugs. METHODS We reviewed the clinical, laboratory and biopsy material of 97 patients diagnosed with erythroderma who were treated in our department over a

Acute generalized exanthematous pustulosis and polyarthritis associated with a novel CARD14 mutation.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Acute generalised exanthematous pustulosis (AGEP) is a rare toxicoderma characterised by an acute onset rash, with many sterile pustules on the surface, high fever and increased acute phase reactants. We report the case of a patient who presented to the dermatology department with an AGEP and

Clinico-etiological study of 30 erythroderma cases from tertiary center in South India.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Erythroderma is a morphological reaction pattern of skin having many underlying causes and finding the etiology helps in the proper management of erythroderma cases. OBJECTIVE To evaluate the clinical profile, etiology of erythroderma and to correlate clinical diagnosis with

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye